MEMORIAL DAY FLASH SALE: 50% OFF BENZINGA PRO
As we honor our freedom, take a stand today. Secure the financial freedom that both you and your family deserve. Get exclusive market moving news for just 50% off. Claim your 50% discount here.
Regeneron Pharmaceuticals (NASDAQ:REGN) has outperformed the market over the past 5 years by 9.56% on an annualized basis producing an average annual return of 17.3%. Currently, Regeneron Pharmaceuticals has a market capitalization of $81.07 billion.
Buying $1000 In REGN: If an investor had bought $1000 of REGN stock 5 years ago, it would be worth $2,186.92 today based on a price of $741.54 for REGN at the time of writing.
Regeneron Pharmaceuticals's Performance Over Last 5 Years
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
MEMORIAL DAY FLASH SALE: 50% OFF BENZINGA PRO
As we honor our freedom, take a stand today. Secure the financial freedom that both you and your family deserve. Get exclusive market moving news for just 50% off. Claim your 50% discount here.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!